Role of pretherapeutic biomarkers in predicting postoperative radiotherapy response in patients with advanced squamous cell carcinoma

International Journal of Radiation Biology

Volumn 77, Issue 11, 2001, Pages 1141-1146

  Rawal, R M ^a   Patel, P S ^a   Vyas, R K ^a   Sainger, R N ^a   Shah, M H ^a   Peshavariya, H M ^a   Patel, D D ^a   Bhatavdekar, J M ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; PROTEIN P21; PROTEIN P53; SUPEROXIDE DISMUTASE;

ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CHEEK MUCOSA; CLINICAL ARTICLE; DISEASE MARKER; ENZYME ACTIVITY; HUMAN; MALE; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CATALASE; COMBINED MODALITY THERAPY; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MOUTH MUCOSA; MOUTH NEOPLASMS; ONCOGENE PROTEIN P21(RAS); POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROTEIN KINASE C; REFERENCE VALUES; SUPEROXIDE DISMUTASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034762097     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/09553000110067788     Document Type: Article

References (39)

1. Catalase in vitro
2. Co-expression of BCl2, c-myc and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma
3. Role of glutathione in the aerobic radiation response
4. Ras oncogene in human cancer: A review
5. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines
6. The p53 gene as a modifier of intrinsic radiosensitivity: Implications for RT
7. Glutathione reductase
8. Oncogenes and radiosensitivity
9. What role do glutathione S-transferase play in the cellular response to ionizing radiation?
10. 1 arrest or protein levels of p53, myc, ras or faf in human melanoma lines
11. The radioresponsiveness of human tumours and the initial slope of the cell survival curve
12. Clinical application of p53 tumour suppressor gene
13. Combined modality therapy for squamous carcinoma of the buccal mucosa: Treatment results and prognostic factors
14. Inherent cellular radiosensitivity as a basic concept for human tumour RT
15. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck
16. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck
17. Overexpression of the p53 gene in head and neck cancer, linked with heavy smoking and drinking
18. Assays for differentiation of glutathione-s-transferase
19. p53 mutations in human cancers
20. Molecular epidemiology of human cancer: Contribution of mutation spectra studies of tumour suppressor genes
21. Epidemiology of oral cancer
22. A modified spectrophotometric assay of superoxide dismutase
23. Relationship between p53 mutation incidence in oral cavity squamous cell carcinoma and patient's tobacco use
24. Protein measurement with the Folin phenol reagent
25. Glutathione level and its relation to radiation therapy in patients with cancer of uterine cervix
26. Immunohistochemical prediction of radiation response and local control in radiation therapy for cervical cancer
27. Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy
28. Oncogene expression and oral cancer
29. p53 over expression in head and neck squamous cell carcinoma: Review of the literature
30. Oxidant and antioxidant activity changes in patients with oral cancer and treated with RT
31. Molecular lesions in human oral cancer: The Indian scene
32. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India
33. The ras oncogene increase the intrinsic resistance in NIH 3T3 cells to ionizing radiation
34. Plasma proteins
35. Radiation induction of immediate early genes: Effectors of the radiation stress response
36. p53 status of head and neck cancer: Relation to biological characteristics and outcome of RT
37. Postoperative radiotherapy for oral cavity cancers: Impact of anatomic subsite on treatment outcome
38. Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: Impact of therapy on patients with positive surgical margins